Stay updated with breaking news from Pcr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Health care professionals review considerations in transitioning breast cancer patients to the adjuvant setting and discuss response monitoring, treatment tailoring, and the evolving role of imaging.
Thermo Fisher Scientific has launched the next-generation Invitrogen™ TaqMan™ Cells-to-CT™ Express Kit, a pioneering solution aimed at providing laboratories with a more sustainable and efficient workflow for gene expression analysis. Click to read more...
New research shows that ctDNA clearance following neoadjuvant treatment of muscle-invasive urothelial cancer can help predict response to therapy and the risk for relapse.
Experts discuss evolving practices in HER2+ breast cancer care, subcutaneous formulations, patient preferences, and resource conservation.
Experts discuss anthracycline use in HER2+ breast cancer and provide insights into how patient scenarios, heterogeneity, and neuropathy concerns shape considerations in diverse clinical situations.